Compare ETY & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETY | ANIP |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | N/A | N/A |
| Metric | ETY | ANIP |
|---|---|---|
| Price | $15.04 | $80.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $107.33 |
| AVG Volume (30 Days) | 247.3K | ★ 543.8K |
| Earning Date | 01-01-0001 | 02-27-2026 |
| Dividend Yield | ★ 7.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.67 |
| Revenue | N/A | ★ $826,880,000.00 |
| Revenue This Year | N/A | $44.19 |
| Revenue Next Year | N/A | $11.25 |
| P/E Ratio | ★ N/A | $48.86 |
| Revenue Growth | N/A | ★ 48.87 |
| 52 Week Low | $10.59 | $54.10 |
| 52 Week High | $13.46 | $99.50 |
| Indicator | ETY | ANIP |
|---|---|---|
| Relative Strength Index (RSI) | 44.37 | 45.67 |
| Support Level | $14.74 | $78.79 |
| Resistance Level | $15.37 | $83.80 |
| Average True Range (ATR) | 0.20 | 2.64 |
| MACD | -0.02 | -0.14 |
| Stochastic Oscillator | 50.79 | 25.82 |
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.